April 23-26, 2006
Baltimore Marriott Waterfront Hotel
Educational Goals and Specific Learning Objectives
- Demonstrate proficiency in administering specific rating scales to evaluate effectiveness and adverse effects of psychiatric medications (pre-meeting workshop).
- Discuss unique issues related to the rating scales used in clinical trials of anxiety disorders.
- Compare and contrast mechanisms of action of antipsychotics and relevance to effectiveness and tolerability.
- Identify the relative merit of various treatment options when first-line interventions do not result in adequate clinical improvement and delineate appropriate interventions for treatment resistant depression.
- Identify target symptoms associated with Pervasive Developmental Disorders which are responsive to pharmacotherapy and discuss the role of various medications in treating these symptoms.
- Define pharmacotherapy plans for the treatment of personality disorders using patient specific factors and an evidence-based medicine approach.
- Identify the stages of mental illness and provide an appropriate response to a consumer or family member dealing with mental illness.
- Compare and contrast the various types of psychotherapy and how they apply to psychiatric pharmacists.
- Describe the incorporation of pharmacotherapy and psychotherapy in the treatment of personality disorders.
- Discuss the impact of the Medicare Modernization Act (MMA) on pharmacy practice.
- Compare factors influencing the pricing of psychiatric medications from industry and managed care perspectives.
- Discuss findings from the CATIE trial and describe the potential impact on psychiatric pharmacy practice.
- Describe the current trends and treatment dilemmas in substance dependence, including alcohol and opioid dependence.
- Describe the application of motivational interviewing techniques to psychopharmacology.
- Describe the potential uses for electronic prescribing in clinical practice.
- Discuss the current options in the treatment of Parkinson's disease and multiple sclerosis
Continuing Education Credit
The College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The 2006 Annual Meeting will provide up to 17 contact hours of continuing education credit from CPNP approved programming. The pre-meeting workshop and home-study literature analysis are provided for an additional 3 and 5 hours respectively.
Continuing nursing education contact hours are also available through the 2006 CPNP Annual Meeting. The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is provided for 17.0 contact hours. The pre-meeting workshop and home-study literature analysis are provided for an additional 3.0 and 5.0 hours respectively. Iowa Provider #78. Additionally, provider approved by the California Board of Registered Nursing, Provider # 13699 for 17 contact hours.
If you are a pharmacist, practitioner, educator, scientist, administrator student, resident, fellow, or nurse practitioner or other healthcare professional involved in the pharmaceutical care of psychiatric and/or neurological patients, we invite you to attend the CPNP Annual Meeting. Through this meeting, practitioners at all levels in the areas of neurology and psychiatry can grow and improve in their specialty areas. The Annual Meeting also benefits those pharmacists who play an ever-increasing role in assuring appropriate drug use, providing overall pharmacotherapy management and enhancing positive outcomes. More importantly, the Annual Meeting provides an opportunity for all attendees to interact and share experiences regarding their areas of common interest.